���构特征与受体作用机制 — What the Evidence Shows

By Editorial Desk · published 2026-06-25 · last reviewed 2026-07-28 · Blog

incretin comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.

Last reviewed on 2026-07-28. Where a claim depends on a specific study, the study is described rather than over-claimed.

结构特征与受体作用机制

皮下注射后吸收相对缓慢，绝对生物利用度约为百分之八十九，血药浓度峰值通常出现在给药后一到三天。与白蛋白结合使清除减慢，终末半衰期约为一百六十五小时，接近一周。连续给药约四到五周后达到稳态暴露水平。表观分布容积约为每千克零点二五升，血浆蛋白结合率超过百分之九十九。代谢以蛋白水解切割和脂肪二酸侧链的 β-氧化为主，相关产物主要经尿液与粪便排出。

序列层面的改动同时解决了两个问题，即酶解稳定性与肾脏清除速度。天然 GLP-1 在循环中的半衰期仅约两分钟，主要被二肽基肽酶-4 迅速灭活。酰化侧链与白蛋白的可逆结合形成循环储库，使分子缓慢释放并持续激活受体。这种设计思路后来被广泛用于同类长效肽的开发，属于该类药物化学改造的典型范式。

Semaglutide 是一种经结构修饰的胰高血糖素样肽-1 类似物，其主链与内源性 GLP-1(7-36) 约有百分之九十四的序列一致性。第 8 位丙氨酸被 α-氨基异丁酸取代，使二肽基肽酶-4 无法识别原有切割位点。第 34 位赖氨酸换为精氨酸，进一步降低酶解速率。第 26 位赖氨酸经间隔基连接一条含十八个碳的二酸脂肪链，该侧链赋予分子与血浆白蛋白结合的能力。

Storage, Handling, and Analytical Testing

Lyophilized peptide material is typically stored at or below -20 °C, with -80 °C used for longer-term archives. Vials should remain sealed and desiccated because moisture promotes aggregation and hydrolysis. Repeated freeze-thaw cycles are avoided since they can alter peptide conformation and reduce recovery. Once reconstituted, solutions are generally kept at 2-8 °C and used within a defined window. Stability beyond those windows depends on buffer composition and concentration, and exact limits are product-specific rather than universal.

Identity and purity are assessed with reversed-phase high-performance liquid chromatography, which separates the peptide from related impurities by hydrophobicity. Mass spectrometry confirms molecular weight and detects truncation or modification products. Peptide mapping after enzymatic digestion verifies the amino acid sequence. Quantitation is often performed by LC-MS/MS or by immunoassay, and the two approaches can give different values because they measure different things. Method validation parameters such as accuracy, precision, and limit of quantitation are reported alongside results.

Certificate of analysis documents from suppliers typically report purity by chromatographic area, water content, and counter-ion identity. Independent verification is advisable because reported values can be generated under differing conditions. Impurity profiles matter for research use, where aggregates, deamidation products, and residual solvents may influence experimental results. Container, lot, and chain-of-custody records support traceability. Analytical results are method-dependent, so comparisons between laboratories require the same procedure and reference standards.

Semaglutide at a glance

Background and Molecular Profile

Two principal therapeutic variants exist under separate regulatory filings, one indicated for glycemic control in type 2 diabetes and one for chronic weight management. Both use the same active molecule; differences lie in formulation strength, titration schedule, and labeling. Regulatory agencies in the United States and European Union approved injectable forms in 2017 and 2018 respectively. An oral tablet formulation received approval later, using a carrier molecule to enhance absorption across the gastric epithelium. Labeling differs by jurisdiction and by indication.

The distinction between established facts and open questions matters here. That the peptide binds the GLP-1 receptor and stimulates insulin release in a glucose-dependent manner is well documented. How individual variability in receptor density, gastric emptying rate, and gut microbiome composition shapes response remains an active research area. Long-term outcomes beyond five years of continuous use are not yet fully characterized in published trials, and several extension studies are ongoing.

Related pages on this site

• Scalable notes
• Modern checklist
• Quality update
• Portable briefing
• Smart notes
• Scalable report
• Material collection
• Portable analysis

Semaglutide Background and Drug Class

Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, developed by Novo Nordisk and first approved in 2017 for type 2 diabetes. It belongs to the incretin mimetic class, a group of agents that reproduce the glucose-dependent actions of endogenous GLP-1. The molecule was engineered to resist degradation by dipeptidyl peptidase-4 and to bind serum albumin, extending its half-life from minutes to roughly one week. Approval for chronic weight management followed in 2021, based on large cardiovascular and obesity outcome trials.

GLP-1 receptors are expressed on pancreatic beta cells, in the gut, and in several brain regions. Receptor activation raises cyclic AMP, enhances glucose-dependent insulin secretion, and suppresses glucagon release when blood glucose is high. Effects on gastric emptying and on hypothalamic appetite circuits reduce energy intake. Because insulin release remains glucose-dependent, the risk of hypoglycemia is low when the drug is used alone. The precise contribution of each pathway to body weight change in humans remains an area of active investigation.

Clinical studies of semaglutide generally measure glycated hemoglobin, fasting plasma glucose, body weight, and composite cardiovascular endpoints. The SUSTAIN program enrolled adults with type 2 diabetes, while the STEP program focused on obesity without diabetes. Administration follows a stepwise escalation schedule designed to limit gastrointestinal effects during the first weeks. Reported outcomes include mean percentage weight change, the proportion of participants reaching defined weight-loss thresholds, and rates of nausea, vomiting, and diarrhea. Long-term data on durability after treatment stops are still limited and remain a topic of ongoing research.

Further detail

=== Threats to other countries === Trump set his sights on a number of countries in the following days. Trump signaled an eagerness to apply pressure on Colombia and said when asked that a similar operation there "sounds good to me". Trump threatened Colombia's president Gustavo Petro, saying he has "cocaine mills and cocaine factories" and "likes making cocaine and selling it to the United States" but would not be doing it much longer. Trump had recently sanctioned the Colombian leader for his alleged reluctance to combat drug trafficking in the country. Petro promised to take up arms if he had to, and Colombia's Ministry of Foreign Affairs issued a statement opposing "an undue interference" in domestic politics. Days later Trump and Petro agreed in a phone call to work together on combating drug trafficking and domestic insurgency, with Petro demanding that Trump "strike hard" against the ELN in both Venezuela and Colombia; Petro said fighting the ELN "in the rear" was just as critical as attacking it inside Colombia. Trump threatened Mexico and Cuba, saying the two nations needed to do more to earn US favor, but said the latter might "fall" without US interference; he also expressed hope that Mexico would act on its own. In an appearance on Hannity Trump said that "We are going to start now hitting land with regard to the cartels. The cartels are running Mexico". Newsweek noted that Trump had said land strikes were imminent before, but also that he had been doing the groundwork by designating cartels Foreign Terrorist Organizations.

Extrion became the dominant manufacturer of ion implanters. By the late 1970s, ion implantation was standard practice throughout the semiconductor industry, enabling the MOS integrated circuits that would dominate late twentieth-century electronics.

== Medical uses == Norgestrienone was used in hormonal contraception to prevent pregnancy. It has typically been used as an oral contraceptive at a dosage of 2 mg/day in combination with ethinylestradiol and 350 μ/day when used alone.

Sources: en.wikipedia.org

Background from the literature

=== Muscle tone === Individuals with decreased muscle tone, increased soft tissue around the airway, and structural features that narrow the airway are at high risk for OSA. Men, whose anatomy is typified by increased mass in the torso and neck, are at increased risk of developing sleep apnea, especially in middle age and later. Typically, women experience this condition less frequently and to a lesser degree than do men, owing partially to physiology, but possibly also to differential levels of progesterone. Prevalence in post-menopausal women approaches that of men in the same age range. Women are at greater risk for developing OSA during pregnancy.

== Research == Anastrozole is surprisingly ineffective at treating gynecomastia, in contrast to selective estrogen receptor modulators like tamoxifen. Anastrozole was under development for the treatment of female infertility but did not complete development and hence was never approved for this indication. An anastrozole and levonorgestrel vaginal ring (developmental code name BAY 98–7196) was under development for use as a hormonal contraceptive and treatment for endometriosis. Development was discontinued in November 2018, and the formulation was never marketed. Anastrozole increases testosterone levels in males and has been studied as an alternative method of androgen replacement therapy in men with hypogonadism. However, there are concerns about its long-term influence on bone mineral density in this patient population, as well as other adverse effects.

{\displaystyle {\begin{aligned}M_{\mathrm {n} }&={\frac {\sum M_{i}N_{i}}{\sum N_{i}}}&&M_{\mathrm {w} }={\frac {\sum M_{i}^{2}N_{i}}{\sum M_{i}N_{i}}}\\M_{\mathrm {z} }&={\frac {\sum M_{i}^{3}N_{i}}{\sum M_{i}^{2}N_{i}}}&&M_{\mathrm {v} }=\left[{\frac {\sum M_{i}^{1+a}N_{i}}{\sum M_{i}N_{i}}}\right]^{\frac {1}{a}}\end{aligned}}}

=== Negotiated values === Results of an impact factor can change dramatically depending on which items are considered as "citable" and therefore included in the denominator. One notorious example of this occurred in 1988 when it was decided that meeting abstracts published in FASEB Journal would no longer be included in the denominator. The journal's impact factor jumped from 0.24 in 1988 to 18.3 in 1989. Publishers routinely discuss with Clarivate how to improve the "accuracy" of their journals' impact factor and therefore get higher scores. Such discussions routinely produce "negotiated values" which result in dramatic changes in the observed scores for dozens of journals, sometimes after unrelated events like the purchase by one of the larger publishers.

Sources: en.wikipedia.org

Further detail

== Further reading == Bryan, J. III; Reed, Philip G. (1945). Mission Beyond Darkness: The story of USS Lexington's Air Group 16 June 20, 1944 attack on the Japanese carrier fleet as told by the men who flew that day. New York: Duell, Sloan and Pearce. OCLC 899039875. Buell, Thomas B. (1974). The Quiet Warrior: A Biography of Admiral Raymond A. Spruance. Boston: Little, Brown & Co. ISBN 0-316-11470-7. OCLC 1036813407. OL 5041914M. Retrieved 25 November 2020. D'Albas, Andrieu (1965). Death of a Navy: Japanese Naval Action in World War II. New York: Devin-Adair. ISBN 0-8159-5302-X. Dull, Paul S. (1978). A Battle History of the Imperial Japanese Navy, 1941–1945. Annapolis, Maryland: Naval Institute Press. ISBN 0-87021-097-1. Hornfischer, James D. (2016). The Fleet at Flood Tide: The U.S. at Total War in the Pacific, 1944–1945. Random House. ISBN 978-0-345-54872-6. Lacroix, Eric; Wells, Linton (1997). Japanese Cruisers of the Pacific War. Annapolis, Maryland: Naval Institute Press. ISBN 0-87021-311-3. Smith, Douglas V. (2006). Carrier Battles: Command Decision in Harm's Way. Annapolis, Maryland: Naval Institute Press. ISBN 1-59114-794-8. Toll, Ian W. (2015). The Conquering Tide: War in the Pacific Islands, 1942–1944. New York: W. W. Norton.

The EPA have some regulations and guidelines for monitoring nitrogen dioxide levels. Historically, some states in the US including Chicago, Northeast corridor and Los Angeles have had high levels of nitrogen dioxide. In 2006, the WHO estimated that over 2 million deaths result annually from air pollution in which nitrogen dioxide constitute one of the pollutants. While over 50% of the disease that results from these pollutants are common in developing countries and the effects in developed countries is also significant. An EPA survey in the US suggests that 16 percent of United States' housing units are sited close to an airport, highway or railroad increasing in the United States the exposure risk of approximately 48 million people. A feasibility study of the ozone formed from the oxidation of nitrogen dioxide in ambient air reported by the WHO suggested that daily deaths of 1 to 2% is attributed to exposure to ozone concentration above 47.3 ppb and exposure above 75.7 ppb is attributed to 3 to 5% increase in daily mortality. A level of 114 ppb was attributed to 5 to 9% increase daily mortality. Silo filler's disease is pervasive during the harvest seasons of food grains. In May 2015, the National Green Tribunal directed Delhi and other states in India to ban diesel vehicles over 10 years old as a measure to reduce nitrogen dioxide emission that may result in nitrogen dioxide poisoning. In 2008, the report of United Kingdom Committee on the Medical Effects of Air Pollutants (COMEAP) suggested that air pollution is the cause of about 29,000 deaths in UK.

Gone with the Wind itself may have been briefly overtaken by The Ten Commandments (1956), which closed at the end of 1960 with worldwide rentals of $58–60 million compared to Gone with the Wind's $59 million; if it did claim the top spot its tenure there was short-lived, since Gone with the Wind was re-released the following year and increased its earnings to $67 million. Depending on how accurate the estimates are, the 1959 remake of Ben-Hur may also have captured the record from Gone with the Wind: as of the end of 1961 it had earned $47 million worldwide, and by 1963 it was trailing Gone with the Wind by just $2 million with international takings of $65 million, ultimately earning $66 million from its initial release.

Sources: en.wikipedia.org

Frequently asked questions